Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Pediatric Blood & Cancer|July 11, 2020
CD14/16 monocyte profiling in juvenile myelomonocytic leukemiaManisha Gadgeel, Shruti Bagla, Steven Buck, et al.Journal of Pediatric Hematology/Oncology|December 28, 2020
Childhood B-Cell Acute Lymphoblastic Leukemia Following SARS CoV-2 Infection: A Potential Second "Hit" in LeukemogenesisYogindra Persaud, Mark Shamoun, Meera Chitlur, et al.The Journal of Pediatrics|October 26, 2016
Intravenous Ferric Carboxymaltose in Children with Iron Deficiency Anemia Who Respond Poorly to Oral IronJacquelyn M Powers, Mark Shamoun, Timothy L McCavit, et al.Frontiers in Oncology|May 3, 2024
Real-world outcomes on platinum-containing chemotherapy for <i>EGFR</i>-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitorsBalazs Halmos, Pragya Rai, Jae Min, et al.Scientific Reports|April 13, 2021
Characterizing bulk rigidity of rigid red blood cell populations in sickle-cell disease patientsMario Gutierrez, Mark Shamoun, Katie Giger Seu, et al.Inorganic Chemistry|July 15, 2009
Oxidation of the natural amino acids by a ferryl complex: kinetic and mechanistic studies with peptide model compoundsAhmed I Abouelatta, Ashley A Campanali, Anil R Ekkati, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2024
Pembrolizumab Plus Chemotherapy for Metastatic NSCLC With Programmed Cell Death Ligand 1 Tumor Proportion Score Less Than 1%: Pooled Analysis of Outcomes After Five Years of Follow-UpShirish M Gadgeel, Delvys Rodríguez-Abreu, Balazs Halmos, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 9, 2024
The Phase 3 KEYLYNK-006 Study of Pembrolizumab Plus Olaparib Versus Pembrolizumab Plus Pemetrexed as Maintenance Therapy for Metastatic Nonsquamous NSCLCJhanelle E Gray, Michael Schenker, Mehmet Ali Nahit Şendur, et al.Pageof 1